Status:
COMPLETED
18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study
Lead Sponsor:
University Health Network, Toronto
Conditions:
Pancreatic Cystic Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overlap of morphological imaging features results in many incidentally detected pancreatic cystic neoplasms going undiagnosed, including benign serous cystic neoplasms (SCN) and potentially malign...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with known pancreatic cystic lesions, including suspected pancreatic serous cystic neoplasms and non-serous cystic neoplasms
- Exclusion criteria:
- General Contraindications to MRI such as pacemaker, brain aneurysm clip etc. -
- Pregnancy
- Age below 18 years
- Estimated GFR (eGFR \< 30 mL/min)
- MRI contrast allergy;
Exclusion
Key Trial Info
Start Date :
June 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2018
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03352037
Start Date
June 15 2017
End Date
July 31 2018
Last Update
April 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 1Z5